continuity of failure.what you think will happen if no...

First 128 Last

Share
Profile

Follow
Empty Nose

4,234 Posts.

610

15/08/23

13:54

Post #: 69347665
Share

Originally posted by WoodySpoon: ↑

@sirhsv

Interesting.
I wonder if they use company funds to pay for that calling campaign.
I bet they do.
The vote must be close enough to have them concerned.

Keeping Fraser (however you might not like the last year of his performance) keeps any continuity concerns at bay. The other two incumbents are completely superfluous to any negotiations given they are almost certainly not any part of them - and can hardly stand on their own records.

I've voted to keep Fraser, Yes to two new directors, and no to Hep and Gordon. Gives us both continuity, fresh eyes on what has gone on, and integrity on what is to come IMHO. Fraser cannot push on with any full sale plan without the two new directors support. They will have our best interests at heart being large holders with their own skin in the game. Best of both worlds IMO.

Expand

continuity of failure.

what you think will happen if no "continuity".
some prospective buyer (of FFX or morila or whatever) which has been negotiating for months will just say, "oh well, we give up"
if it's a genuine deal, they will continue willingly to deal with the new directors.
continuity, what a dumb excuse for failure.

Last edited by Empty Nose: 15/08/23

FFX Price at posting: 20.0¢ Sentiment: Hold Disclosure: Held
15 Upvote

1 Great analysis

Reply

Top Stories

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

'Not possible' to port renewable gas: ACCC takes AGN to court

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

BOE

Boss extends June win streak with boosted Alta Mesa extraction rates

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

First 128 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

continuity of failure.what you think will happen if no...

Top Stories

Australia’s gas crisis is here – and dying coal plants aren’t helping

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

'Not possible' to port renewable gas: ACCC takes AGN to court

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Boss extends June win streak with boosted Alta Mesa extraction rates

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Featured News